Uncategorized

Inventiva and Echosens announce their collaboration in raising awareness about NASH and increase access to screening for patients at risk of developing NASH.

The documents come just two days before an advisory committee is scheduled to vote on the Alzheimer’s drug.

The FDA’s marketing authorization for Cue’s COVID-19 molecular test could boost consumer access, but the company faces strong competition from more established diagnostic firms.

Despite stable financial performance from the nation’s largest insurers, provider cost pressures could be reflected through contract negotiations and subsequent premium rate increases over the next few years, according to Fitch Ratings.

A federal appeals court judge denied Medtronic’s claims that Teleflex’s catheters were unpatentable.

Un estudio del Consejo Superior de Investigaciones Científicas (CSIC) en España ha evaluado los efectos del fuego sobre las comunidades de hormigas y abejas en pinares mediterráneos de Andalucía.   Sus resultados a corto y largo plazo podrían sugerir que los …

Un nuevo anticuerpo conjugado podría ser útil para personalizar el tratamiento de pacientes con cáncer epitelial de ovario recurrente que expresan la proteína FolR-alfa.   Los resultados preliminares del ensayo clínico fase I STRO-002-GM1 de expansión …

Mayo, a longstanding collaborator of Google’s, will be an early adopter of a Google Cloud tool that allows organizations to create chatbots and other search applications using generative AI.

Patients of color, or those with public insurance, were more likely than White patients to experience adverse health events after surgery, regardless of hospital safety ratings, according to a new Leapfrog report.

Using artificial intelligence to examine dental X-rays can nearly double diagnostic accuracy, and help detect other diseases.